Case Report
Published on 08 Oct 2025
Case report: Anlotinib plus oral etoposide: a potential salvage therapy based on insights from EGFR-TKI-resistant SCLC transformation PDX and clinical settings
in Thoracic Oncology
- 523 views
Case Report
Published on 08 Oct 2025
in Thoracic Oncology
Original Research
Published on 08 Oct 2025
in B Cell Biology
Case Report
Published on 08 Oct 2025
in Otorhinolaryngology - Head and Neck Surgery
Original Research
Published on 08 Oct 2025
in Exercise Physiology
Case Report
Published on 08 Oct 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Published on 08 Oct 2025
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Published on 08 Oct 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Published on 08 Oct 2025
in Neuro-Otology
Original Research
Published on 08 Oct 2025
in Pulmonary Medicine
Original Research
Published on 08 Oct 2025
in Orthopedic Surgery
Original Research
Published on 08 Oct 2025
in Digital Impacts
Systematic Review
Published on 08 Oct 2025
in Sport Psychology
Original Research
Published on 08 Oct 2025
in Integrative Physiology
Review
Published on 08 Oct 2025
in T Cell Biology
Original Research
Published on 08 Oct 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 08 Oct 2025
in Pediatric Pulmonology